Assessing the effectiveness of state-level pharmacy laws on opioid prescribing practices

Authors

  • Pranjul Shrivastava
  • Syed Sajid Ali Syed Sabir Ali

Keywords:

healthcare, Medicine, pharmacy, ADR.

Abstract

Despite their positive impacts on health, medications can have negative side effects because of adverse drug reactions (ADRs). Physicians, pharmacists, and nursing staff have a duty to use caution while prescribing medication. Patients are becoming more conscious of drug-related issues in today's consumer-driven world, and they want to be included in the decision-making process for many elements of their prescription and health care. This study concludes that polypharmacy, a history of bad drug responses, and coexisting illnesses are independent predictors of adverse drug reactions. Elderly people are more susceptible to adverse drug reactions due to comorbidity and a higher number of medications. Although not statistically significant, this study indicated that male gender, age, and comorbidity are associated with a higher risk of adverse drug responses (ADRs). It also implies that more research is necessary to determine whether there is a clear link between male sex and adverse drug reactions. The most important and noteworthy stage in drug safety is adverse drug reaction monitoring, which lowers the morbidity and death associated with ADRs. When prescription medication, especially to vulnerable age groups, healthcare providers should be more aware of adverse drug reactions (ADRs) and take all factors into account.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Whitmore CC, White MN, Buntin MB, Fry CE, Calamari K, Patrick SW. State laws and policies to reduce opioid-related harm: A qualitative assessment of PDMPs and naloxone programs in ten US States. Preventive medicine reports. 2019 Mar 1;13:249-55.

Xu J, Mukherjee S. State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmacies. Drug and alcohol dependence. 2021 Oct 1;227:109012.

McGinty EE, Bicket MC, Seewald NJ, Stuart EA, Alexander GC, Barry CL, McCourt AD, Rutkow L. Effects of state opioid prescribing laws on use of opioid and other pain treatments among commercially insured US adults. Annals of internal medicine. 2022 May;175(5):617-27.

Hlushenkova A, Kalinin O, Navrozova Y, Navolokina A, Shcherbyna V, Doroshenko T. Management of Strategies for Shaping the Innovative and Investment Potential of Enterprises as a Factor Ensuring Their Economic Security. Indian Journal of Information Sources and Services. 2024;14(3):16-22. https://doi.org/10.51983/ijiss-2024.14.3.03

Haegerich TM, Paulozzi LJ, Manns BJ, Jones CM. What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug and alcohol dependence. 2014 Dec 1;145:34-47.

Arvinth N. Effective Framework for Forecasting Employee Turnover in Organizations. Global Perspectives in Management. 2024;2(3):24-31.

Das R. Evaluating the policy response to curb the opioid prescribing behaviour of physicians in the United States. Public Administration and Policy. 2023 Nov 13;26(3):250-7.

Kong Y, Suntrayuth S, Lin F. Construction of Cross-Border E-Commerce Supply Chain of Agricultural Food Products based on Blockchain Technology. Natural and Engineering Sciences. 2024 Sep 1;9(2):145-63.

Lee B, Zhao W, Yang KC, Ahn YY, Perry BL. Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018. JAMA network open. 2021 Feb 1;4(2):e2036687-.

Najafi A. The relationship between parenting style and mental health. International Academic Journal of Humanities. 2016;3(1):1-5. Retrieved from https://iaiest.com/iaj/index.php/IAJH/article/view/IAJH1510001

Abouk R, Pacula RL, Powell D. Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose. JAMA internal medicine. 2019 Jun 1;179(6):805-11.

Wilson MN, Hayden JA, Rhodes E, Robinson A, Asbridge M. Effectiveness of prescription monitoring programs in reducing opioid prescribing, dispensing, and use outcomes: a systematic review. The Journal of Pain. 2019 Dec 1;20(12):1383-93.

Kumar S. Exploring Pharmaist Challenges with Pubmed Studies with Relational Prescribing. Clinical Journal for Medicine, Health and Pharmacy. 2024 Sep 30;2(3):11-20.

Nishide T, Miyazaki S, Sakurai K. Security Analysis of Offline E-cash Systems with Malicious Insider. J. Wirel. Mob. Networks Ubiquitous Comput. Dependable Appl.. 2012 Mar;3(1/2):55-71.

Kakavand ZM, Chalechale A. Comparison of Two Different Distance Functions of Image Retrieval for Detecting Species of Microscopic Fungi in Medical Mycology Laboratory. International Academic Journal of Science and Engineering, 2 (4), 39. 2015;44. Retrieved from https://iaiest.com/iaj/index.php/IAJSE/article/view/1324

Kao YC, Liu JC, Wang YH, Chu YH, Tsai SC, Lin YB. Automatic Blocking Mechanism for Information Security with SDN. J. Internet Serv. Inf. Secur.. 2019 Feb;9(1):60-73.

Beaudoin FL, Banerjee GN, Mello MJ. State-level and system-level opioid prescribing policies: the impact on provider practices and overdose deaths, a systematic review. Journal of opioid management. 2016 May;12(2):109.

Bao Y, Wen K, Johnson P, Jeng PJ, Meisel ZF, Schackman BR. Assessing the impact of state policies for prescription drug monitoring programs on high-risk opioid prescriptions. Health Affairs. 2018 Oct 1;37(10):1596-604.

Downloads

Published

2025-02-04

How to Cite

1.
Shrivastava P, Syed Sabir Ali SSA. Assessing the effectiveness of state-level pharmacy laws on opioid prescribing practices. J Neonatal Surg [Internet]. 2025Feb.4 [cited 2025Feb.14];14(1S):323-8. Available from: https://jneonatalsurg.com/index.php/jns/article/view/1540

Most read articles by the same author(s)